Skip to main content
. 2021 Mar 24;11(8):2265–2285. doi: 10.1016/j.apsb.2021.03.033

Table 2.

The paths of targeted reconstruction of tumor stroma.

Target Path
TVEC The normalization of tumor vasculature
ECM Inhibiting of collagen synthesis
Degradation of stromal collagen
Hyaluronic acid as a therapeutic target
Treatment of hypoxia
CAFs Paracrine pathway
Remodeling ECM
Promoting tumor angiogenesis
Targeting CAFs to normalize tumor stiffness
Reprogramming CAFs to an immunosupportive state

TVEC, tumor vascular endothelial cells; ECM, extracellular matrix; CAFs, cancer-associated fibroblasts.